2425 55th Street, Suite 210 Boulder, CO 80301 303-420-4420

News

Bolder BioTechnology Announces Scientific Presentations at the 2019 Radiation Research Society Annual Meeting

Boulder, Colorado – November 7, 2019 - Bolder BioTechnology is pleased to announce that three scientific presentations describing use of the company’s novel interleukin-11 analog BBT-059 to treat acute radiation syndrome were given at the Radiation Research Society annual meeting held November 3-6, 2019 in San Diego, CA. An invited oral presentation entitled “Pegylated IL-11…
Read more

Bolder BioTechnology to Present Preclinical Data for Three Research Programs at Acute Radiation Syndrome Meeting

Boulder, Colorado – October 24, 2018- Bolder BioTechnology, Inc. announced today that Dr. Joe Cox, Company President, will give an oral presentation at the “A Poly-Pharmacy Approach to Mitigate Acute Radiation Syndrome (ARS)” meeting being held October 25, 2018 at the National Institute of Allergy and Infectious Diseases Conference Center, 5601 Fishers Lane, Rockville, Maryland.…
Read more